The Cannabis Corner
The Cannabis Corner is an open conversation about marijuana and where it is headed in America. As cannabis becomes more mainstream and yet is still misunderstood, The Cannabis Corner strives to bring truthful language to the subject. Hosted by author Joshua Braff and Medical Marijuana CareGiver Adam Titelbaum, this podcast sheds light on questions about medicinal marijuana as a healthier alternative to alcohol or pills. All questions are important. What’s a CBD? What edibles should I try for sleep? How do I know what too much looks like? What is dabbing? Is vaping safer than smoking? Is it safe to buy it where I live? Format includes focused discussion with guests, call-in questions and in Episode One, an interview with actor/director Zach Braff. The goal is to present an accessible and warm community of flat out understanding. We get it, ask us. Have a listen and please let us know what you think - and let us know your questions. See you in the Corner!
The Cannabis Corner
The Cannabis Corner Ep #14: The Migraine Show; Plus Lab Testing, Part Two
•
Joshua Braff, Adam Titelbaum
Welcome to the Migraine Show. This week we speak with Mary, a grandma from CO who has suffered from migraines for 50 years. After years of pharmaceutical use for her intense migraines pain, Mary received huge and quick relief from some cannabis-buttered toast! The occurrences of her migraines has dropped as well. Phyllis speaks of her chromic nerve pain and how a small chocolate edible was the key to fast and lasting relief. We also discuss the stigma of cannabis, and how even in Colorado, it is often a generational matter. We continue our discussion with Isaac Roth of Anresco Labs in San Francisco. Isaac discusses the crucial aspects concerning harvesting a clean enough product for mass distribution in a soon to be very regulated country. The key to successful lab testing is the seeking out of common grower issues at the microbial level and flagging unclean grow rooms for bacteria and fungus. There is a need for professionally-realized grow environments, where extremely expensive harvests may fail to adhere to appropriate health standards. Data is key to this - and it's vital how this data is confirmed and reported to cannabis industry distributors. These data points, according to Isaac, will soon be used at the state level.